Globus Medical, Inc.

GMED Healthcare Medical Devices

Globus Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 16.7% from fiscal 2024. In the quarter to June 2026, revenue grew 5.94%, EPS fell 25.3% and free cash flow grew 571.3%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for three.

76.71 2.13 −2.70%
Market cap
$10.6B
P/E
19.3×
Fwd P/E
20.3×
Dividend yield
—
F-score
9/9
Altman Z
11.30
Beneish M
−2.31
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
11.81% 13.30% 12.29% 10.01%

+8 more TTM periods

Piotroski F-Score
9 9 9 8
ROA
10.25% 11.56% 10.19% 8.32%
ROIC
9.58% 8.12% 7.47% 5.78%
Return on Tangible Assets
23.59% 25.81% 24.54% 20.81%
Average Days of Receivables
85.80 86.57 92.36 90.68
Free Cash Flow per Share
5.59 4.51 4.21 4.16
Free Cash Flow
755.59 610.32 569.02 559.94
Other line items

Show all line items

Columns are period end dates